/
We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
$15.55
$0.39 (-2.45%)
Price from 12 days ago
Operating margin is thin at 5.56%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 97.0% YoY with margins expanding 67.9pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$907M
▲ +97.0% YoY
Net Income (TTM)
$34M
▲ +75.8% YoY
Op. Margin
11.94%
▲ +67.9pp YoY
ROIC
8.99%
▲ +100.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$123M
▲ +126.4% YoY
Op. Cash Flow (TTM)
$147M
▲ +133.9% YoY
Net Debt
-$391M
Net Cash Position
Cash & Equiv.
$822M
Continue Research